降鈣素原(PCT)重組蛋白
Recombinant Procalcitonin (PCT)
Pro-Calcitonin
- 編號(hào)RPA689Mu03
 - 物種Mus musculus (Mouse,小鼠)相同的名稱,不同的物種。
 - 來源原核表達(dá)
 - 宿主E.coli
 - 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
 - 亞細(xì)胞定位分泌
 - 預(yù)測分子量16.1kDa
 - 實(shí)際分子量16kDa(差異分析請參閱說明書)
 - 片段與標(biāo)簽Val26~Asn136 with N-terminal His Tag
 - 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
 - 性狀凍干粉
 - 純度> 90%
 - 等電點(diǎn)4.8
 - 應(yīng)用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,請參見活性蛋白。 - 下載英文說明書 中文說明書
 - 規(guī)格10μg50μg200μg1mg5mg
 - 價(jià)格¥ 1020¥ 2550¥ 5100¥ 15300¥ 38250
 - 欲了解實(shí)際交易價(jià)格和更多情況,請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
 
序列

用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過一個(gè)月,-80°C不超過12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種:Mus musculus (Mouse,小鼠) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) | 
| RPA689Mu03 | 降鈣素原(PCT)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| RPA689Mu01 | 降鈣素原(PCT)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| EPA689Mu61 | 降鈣素原(PCT)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| RPA689Mu02 | 降鈣素原(PCT)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| PAA689Mu01 | 降鈣素原(PCT)多克隆抗體 | WB; IHC; ICC; IP. | 
| PAA689Mu02 | 降鈣素原(PCT)多克隆抗體 | WB | 
| SEA689Mu | 降鈣素原(PCT)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. | 
| LMA689Mu | 降鈣素原(PCT)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. | 
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) | 
| Scandinavian Journal of Infectious Diseases | Evaluation of neutrophilic CD64, interleukin 10 and procalcitonin as diagnostic markers of early- and late-onset neonatal sepsis[PubMed: 20085423] | 
| International Journal of Radiation Oncology ? Biology ? Physics | Effects of Berberine Against Radiation-Induced Intestinal Injury in Mice[PubMed: 20637981] | 
| Ulus Travma Acil Cerrahi Derg | Diagnostic and prognostic value of procalcitonin and phosphorus in acute mesenteric ischemia[PubMed: 21935794] | 
| Egyptian Journal of Bronchology | Serum procalcitonin and its relation to the outcome of ventilator-associated pneumoniain children[Essbronchology: Source] | 
| University of Waikato | The Assessment of Vitamin D, Antimicrobial Peptides and Procalcitonin in Bronchiectasis[Waikato:Source] | 
| Egyptian Journal of Medical Microbiology | Evaluation of the Diagnostic Utility of Fc Gamma Receptor Type 1 (nCD64) and Procalcitonin in Comparison with Conventional Methods for Diagnosis of Early Onset Neonatal Sepsis[Ejmm:Source] | 
| Nigerian Medical Journal | Efficacy of measuring procalcitonin levels in determination of prognosis and early diagnosis of bacterial resistance in sepsis[Pubmed:25657488] | 
| Wiley online library | The use and value of procalcitonin in solid organ transplantation[PubMed: 25996831] | 
| Balkan Med J | Diagnostic Value of Procalcitonin Levels in Acute Mesenteric Ischemia[PubMed: 26185718] | 
| The Journal of Clinical Endocrinology & Metabolism | Macrocalcitonin is a novel pitfall in the routine of serum calcitonin immunoassay[PubMed: 26647152] | 
| Journal of Human Hypertension | Procalcitonin and Pentraxin-3: Current biomarkers in inflammation in white coat hypertension[PubMed: 26040439] | 
| Medical Science Monitor | Variation?of?Circulating?Inflammatory?Mediators?in?Staphylococcus?aureus?and?Escherichia?coli?BloodstreamInfection.[Pubmed:26772168] | 
| International Immunopharmacology | Consistency and pathophysiological characterization of a rat polymicrobial sepsis model via the improved cecal ligation and puncture surgery[Pubmed:26802602] | 
| Pancreatology. | Early prediction of intestinal mucosal barrier function impairment by elevated serum procalcitonin in rats with severe acute pancreatitis.[Pubmed:26804005] | 
| Acta?Medica | Risk Factors?of?Acute?Pancreatitis?in?Oral?Double Balloon Enteroscopy.[pubmed:27638962] | 
| The Clinical Respiratory Journal | Changes in inflammatory mediators as a result of intermittent hypoxia in obstructive sleep apnea syndrome[pubmed:28960823] | 
| SHOCK | INTERLEUKIN-1 RECEPTOR 2: A NEW BIOMARKER FOR SEPSIS DIAGNOSIS AND GRAM-NEGATIVE/GRAM-POSITIVE BACTERIAL DIFFERENTIATION[pubmed:27984536] | 
| Cellular?Physiology and Biochemistry | Hepatic Macrophages are the Cell Source of Hepatic Procalcitonin in Acute Liver Failure[Pubmed:29913443] | 
| Archives of Medical Science | Inflammatory mediators in the diagnosis and treatment of acute pancreatitis: pentraxin-3, procalcitonin and myeloperoxidase[Pubmed:29593801] | 
| Journal of Thoracic Disease | Expression pattern of soluble triggering receptor expressed on myeloid cells-1 in mice with Acinetobacter baumannii colonization and infection in the lung[Pubmed:29707313] | 
| Asian?Journal of Psychiatry | Procalcitonin and C-reactive protein as peripheral inflammatory markers in antipsychotic drug-free schizophrenia patients[Pubmed:29723719] | 
| European Review for Medical and Pharmacological Sciences | The predictive value of joint detection of serum amyloid protein A, PCT, and Hs-CRP in the diagnosis and efficacy of neonatal septicemia.[Pubmed: 31298341] | 
| Medicina | Modestly Elevated Serum Procalcitonin Levels in Patients with Rheumatoid Arthritis Free of Active Infection[Pubmed: 33080909] | 
| MEDIATORS OF INFLAMMATION | Reevaluation of Lung Injury in TNF-Induced Shock: The Role of the Acid Sphingomyelinase[Pubmed: 32410851] | 
| Early label-free analysis of mitochondrial redox states by Raman spectroscopy predicts septic outcomes[] | |
| Journal of Immunology Research | Moesin Is a Novel Biomarker of Endothelial Injury in Sepsis[33628853] | 
| Journal of Medical Biochemistry | Circulating nuclear factor-kappa B mediates cancer-associated inflammation in human breast and colon cancer[33776564] | 
| Surg Endosc | Original contribution: sleeve gastrectomy reduces soluble lectin-like oxidized low-density lipoprotein receptor-1 (sLOX-1) levels in patients with morbid obesity[Pubmed:35044516] | 
| Bone Res | Procalcitonin is expressed in osteoblasts and limits bone resorption through inhibition of macrophage migration during intermittent PTH treatment[Pubmed:35087025] | 



